← Eichor
Study identifier: NCT07721571 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Nephrostomy Tract Infiltration for Pain Control After PCNL

Condition: Postoperative Pain · Kidney Calculi  ·  Sponsor: Hitit University

PhaseNA
Planned participants60
Who can joinAll sexes, 18 Years to 75 Years
Healthy volunteersNo

About this study

This prospective, randomized, controlled clinical trial aims to evaluate the effectiveness of nephrostomy tract local anesthetic infiltration for postoperative pain control in patients undergoing prone percutaneous nephrolithotomy. Eligible patients will be randomly assigned to either a control group receiving standard systemic postoperative analgesia or an intervention group receiving standard analgesia plus infiltration of 20 mL of 0.25% bupivacaine along the nephrostomy tract at the end of surgery. Postoperative pain will be assessed using the Visual Analog Scale at 1, 6, 12, and 24 hours. Secondary outcomes will include time to first analgesic requirement, total opioid consumption during the first 24 hours, need for rescue analgesia, time to mobilization, length of hospital stay, and treatment-related complications. The study is designed to determine whether nephrostomy tract infiltration provides a simple, safe, and effective adjunct for reducing pain and analgesic consumption after percutaneous nephrolithotomy.

This description comes directly from the study's public registry record.

Talk to the study team

MUSTAFA SERDAR ÇAĞLAYAN  ·  +905074311951  ·  serdar.09.09@hotmail.com

Always discuss trial participation with your own doctor first.

Locations (1)

Department of Urology, Hitit University Çorum Erol Olçok Training and Research Hospital, Çorum, TürkiyeÇorum, Çorum, Turkey (Türkiye)Recruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT07721571